Impact of photobiomodulation in the salivary flow of patients treated with radiotherapy and chemotherapy for head and neck cancer: double blind and randomized pilot study.

Próprio pesquisador0 个研究点开始时间: 2020年5月4日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Patients with cancer of the head and neck (oral cavity, pharynx, larynx and occult primary) with indication of treatment with radiotherapy; Patients that the irradiation field must include all major salivary glands.

•Patients younger than 18 years or incapacitated to answer questions; Initial tumors (T1 and T2) and limited to the larynx, other sites such as metastases and skin tumors; Indication of RT with palliative intent; Patients with Diabetes Melitus, autoimmune, infectious and collagen diseases.
•Patients who use drugs that may interfere with the salivary flow; Patients with trismus or limitation of mouth opening due to surgical sequelae.

发起方

Próprio pesquisador